Hypophosphatasia: Enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults
Publication
, Conference
Kishnani, PS; Rockman-Greenberg, C; Whyte, M; Weber, T; Mhanni, A; Madson, K; Reeves, A; Mack, K; Plotkin, H; Kreher, N; Landy, H
Published in: MOLECULAR GENETICS AND METABOLISM
March 1, 2012
Duke Scholars
Published In
MOLECULAR GENETICS AND METABOLISM
ISSN
1096-7192
Publication Date
March 1, 2012
Volume
105
Issue
3
Start / End Page
328 / 329
Location
Charlotte, NC
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Conference Name
35th Annual Meeting of the Society-for-Inherited-Metabolic-Disorders (SIMD)
Related Subject Headings
- Genetics & Heredity
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kishnani, P. S., Rockman-Greenberg, C., Whyte, M., Weber, T., Mhanni, A., Madson, K., … Landy, H. (2012). Hypophosphatasia: Enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults. In MOLECULAR GENETICS AND METABOLISM (Vol. 105, pp. 328–329). Charlotte, NC: ACADEMIC PRESS INC ELSEVIER SCIENCE.
Kishnani, Priya S., Cheryl Rockman-Greenberg, Michael Whyte, Thomas Weber, Azziz Mhanni, Katherine Madson, Amy Reeves, et al. “Hypophosphatasia: Enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults.” In MOLECULAR GENETICS AND METABOLISM, 105:328–29. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2012.
Kishnani PS, Rockman-Greenberg C, Whyte M, Weber T, Mhanni A, Madson K, et al. Hypophosphatasia: Enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults. In: MOLECULAR GENETICS AND METABOLISM. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2012. p. 328–9.
Kishnani, Priya S., et al. “Hypophosphatasia: Enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults.” MOLECULAR GENETICS AND METABOLISM, vol. 105, no. 3, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2012, pp. 328–29.
Kishnani PS, Rockman-Greenberg C, Whyte M, Weber T, Mhanni A, Madson K, Reeves A, Mack K, Plotkin H, Kreher N, Landy H. Hypophosphatasia: Enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults. MOLECULAR GENETICS AND METABOLISM. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2012. p. 328–329.
Published In
MOLECULAR GENETICS AND METABOLISM
ISSN
1096-7192
Publication Date
March 1, 2012
Volume
105
Issue
3
Start / End Page
328 / 329
Location
Charlotte, NC
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Conference Name
35th Annual Meeting of the Society-for-Inherited-Metabolic-Disorders (SIMD)
Related Subject Headings
- Genetics & Heredity
- 1103 Clinical Sciences